Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001209191-21-049793

COO & CBO sold 5,700 shares at $28.87 ($164,554)

  • COO & CBO acquired 5,700 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Nash Huw M. COO & CBO 2021-08-02 Option exercise +5,700 $2.19 $12,483 5,700 D
Nash Huw M. COO & CBO 2021-08-02 Sale −5,700 $28.87 $164,554 0 D
Derivatives
Nash Huw M. COO & CBO 2021-08-02 Option exercise · Employee Stock Option (Right to Buy) −5,700 113,422 D
Open-market sales · 5,700 sh · avg $28.87 · $164,554
Loading xslF345X03/doc4.xml…